Benefit design innovation to manage speciatly pharmaceuticals

Journal of Managed Care Pharmacy

Volumn 14, Issue 4 SUPPL., 2008, Pages

  Stern, Debbie ^a  

^a Rxpert Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; GENERIC DRUG; VACCINE; DRUG;

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG COST; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH ECONOMICS; PATIENT SAFETY; PHARMACEUTICAL CARE; PHARMACOGENOMICS; PHARMACY; PRACTICE GUIDELINE; REIMBURSEMENT; REVIEW; ARTICLE; ECONOMICS; HEALTH INSURANCE; HUMAN; INSURANCE; ORGANIZATION AND MANAGEMENT; UNITED STATES;

DRUG COSTS; HUMANS; INSURANCE BENEFITS; INSURANCE, PHARMACEUTICAL SERVICES; MANAGED CARE PROGRAMS; PHARMACEUTICAL PREPARATIONS; UNITED STATES;

EID: 45849086534     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. BIO (Biotechnology Industry Organization). Approved Biotechnology Drugs. Available at: www.bio.org/speeches/pubs/er/approveddrugs. Accessed July 10, 2007.
2. Butcher L. Newly final CMS policy may help plans when evidence for coverage is lacking. Biotechnol Healthcare. 2006;3:41-45.
3. Medco Drug Trend Report 2007. Available at: www.drugtrend.com. Accessed October 12, 2007.
4. Express Scripts Drug Trend Report 2007. Available at: www.expressscripts.com/ourcompany/news/industryreports/drugtrendreport/ 2006/dtrFinal.pdf. Accessed January 12, 2008.
5. PhRMA. Medicines in Development. Available at: www.phrma.org/ medicines_in_development/. Accessed March 27, 2008.
6. EMD Serono Injectables Digest 3rd Edition, 2007. Available at: www.emdserono.com. Accessed September 28, 2007.
7. Goldman DP, Joyce GF, Lawless G, Crown VVH, Willey V. Benefit design and specialty drug use. Health Aff. (Millwood). 2006;25:1319-31.
8. Silverman E. Copayments: Too much, yet not enough? Biotechnol Healthcare. 2006;2:21-26.
9. Wyllie MG. Diagnostic potential unmasked. BJU Int. 2004;93:627-28.
10. U.S. Food and Drug Administration. FDA News. FDA Clears Genetic Lab Test for Warfarin Sensitivity. Available at: www.fda.gov/bbs/topics/NEWS/2007/ NEW01701.html. Accessed March 27, 2008.